LIF and cholangiocarcinoma: LIF did not induce any significant changes in the phosphorylation levels of STAT3 (Figure 5A, 5B), an effector classically activated by LIF [21], or of ERK1/2 (Figure 5C, 5D) in either CCA cell line.